MindMics

What MindMics does

MindMics Inc. is a Cambridge, Massachusetts–based private health-technology company founded in 2018 by Dr. Anna Barnacka, a former NASA Einstein Fellow at Harvard. The company has pioneered a biosensing modality it calls In-ear Infrasonic Hemodynography (IH), in which miniature microphones embedded in earbuds and hearing aids capture sub-20Hz acoustic vibrations generated by cardiovascular activity in the ear canal. Proprietary AI models, trained on millions of heartbeats, convert those infrasonic signals into heart rate, inter-beat intervals, heart rate variability, and physiological-state classifications with 99% correlation to ECG, regardless of skin tone or body mass.

The product portfolio spans a B2B platform and a consumer system. The MindMics Biosensing AI Platform is delivered as a cloud-based REST API plus a white-label app, with the MindMics Inside program embedding firmware on Qualcomm S5 (QCC5171) and QCC5141 chipsets, plus a Master & Dynamic white-label earbud partnership. The consumer MindMics Heart Health System bundles proprietary infrasonic earbuds, an iOS app, and a 12-month cloud subscription at $349. Clinical validation includes peer-reviewed work with Prisma Health and Scripps Health, publication in Nature Portfolio NPJ Digital Medicine, and patent coverage in the US, China, and India.

MindMics operates a hybrid go-to-market combining direct-to-consumer e-commerce with B2B platform licensing to consumer audio brands, telehealth providers, corporate wellness platforms, and sports performance companies. The company is positioned to monetize through consumer hardware plus recurring subscription, OEM/white-label licensing (chipset royalties, white-label apps), and enterprise API access. The product is explicitly not a regulated medical device, which preserves the consumer/wellness positioning but constrains direct clinical claims.

Name

MindMics

Legal name

MindMics Inc.

Website

https://mindmics.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

MindMics builds an AI-powered biosensing platform that converts infrasonic signals from in-ear microphones into clinical-grade heart rate, HRV, and arrhythmia metrics, serving consumer audio brands, telehealth, wellness, and individual buyers.

Ownership category

akta.pro rank

Product category

Wearable Health Monitoring

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)

akta.pro secondary industries

Hearables (True Wireless Earbuds & Smart Headphones) (CRACAIAD), On-Device Speech & Audio AI (wake word, ASR, enhancement) (HDAAAJAF), Microphones & Acoustic MEMS (MEMS Mics/Ultrasonic Transducers) (HDAHALAH), Audio & Voice Mixed-Signal ICs (Codecs/Amplifiers) (HDAHAIAG)

Keywords

• In-ear biosensing
• Wearable health monitoring
• Heart rate variability
• Infrasonic hemodynography
• Biosignal AI platform

Headquarters

HQ city

Cambridge

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Supply Chain, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Consumer Hardware + Subscription: MindMics sells the MindMics Heart Health System - infrasonic earbuds bundled with a 12-month iOS app subscription for $349. The subscription provides access to the cloud platform for health metrics computation, data storage, and real-time biometric insights.
2. B2B Platform Licensing: Licenses MindMics IH technology, APIs, and white-label apps to enterprise partners including consumer audio brands, healthcare providers, corporate wellness companies, and digital health platforms. Partners embed the technology into their products for health monitoring capabilities.
3. API Access: Enterprise partners access real-time heart and wellness data through secure REST API integration. Enables closed-loop health applications across gaming, smart music playlists, telehealth, and other AI-driven solutions.
4. Qualcomm Extension Program: Technology licensing through Qualcomm's Voice and Music Extension Program, embedding infrasonic hemodynography on Qualcomm S5 Sound Platform (QCC5171) and QCC5141 platform for commercial earbud products.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels6 records

Core offering

MindMics has invented and patented In-ear Infrasonic Hemodynography (IH), a biosensing modality that captures low-frequency acoustic signals (<20Hz) in the ear canal via miniature microphones embedded in earbuds and hearing aids, then processes them through proprietary AI models to deliver clinical-grade heart rate, HRV, inter-beat intervals, and physiological state biometrics. The company sells a B2B Biosensing AI Platform (cloud, REST API, white-label app, and chipset/firmware integration via the MindMics Inside Program for OEMs) and a direct-to-consumer Heart Health System (proprietary Infrasonic Earbuds + iOS app + 12-month cloud subscription) at $349.

Product overview

MindMics offers a B2B biosensing AI platform and consumer-facing product ecosystem built around its patented In-ear Infrasonic Hemodynography (IH) technology. The core offering is the MindMics Biosensing AI Platform — a cloud-based AI engine that processes infrasonic acoustic signals captured by in-ear sensors to deliver real-time biometrics (HR, HRV, inter-beat intervals, physiological state) with 99% ECG correlation. The consumer MindMics Heart Health System combines proprietary Infrasonic Earbuds with the Heart Health mobile app (iOS) and a cloud subscription. For B2B partners, MindMics provides the MindMics Inside Program (firmware/chipset integration), the White-Label App, and a REST API for custom application development. Additional offerings include Infrasonic Lab Services for third-party earbud evaluation and Breathwork Biofeedback as a guided in-app feature.

Differentiator

Problem solved

Functional benefit

Products and services

• MindMics Heart Health System Consumer-facing heart health monitoring bundle that pairs proprietary Infrasonic Earbuds with the Heart Health iOS app and a 12-month cloud subscription, delivering real-time heart rate, HRV, inter-beat intervals, and physiological state tracking with 99% correlation to ECG regardless of skin tone or body mass. Priced at $349 in the US.
• MindMics Infrasonic Earbuds True wireless, noise-canceling earbuds with embedded infrasonic hemodynography sensors that capture sub-20Hz biosignals from the ear canal while simultaneously delivering standard audio playback and voice capture. Designed to be sold as part of the Heart Health System.
• MindMics Heart Health Mobile App (iOS) Heart Health by MindMics iOS app that pairs with the MindMics earbuds (or Polar H10 chest strap) to display real-time heart rate, HRV, inter-beat intervals, and physiological state on a dashboard, and guides users through breathwork exercises. Requires iOS 16+; Apple Health integration.
• MindMics Biosensing AI Platform Cloud-based B2B technology platform that translates in-ear infrasonic physiological data into real-time biometric metrics (inter-beat intervals, heart rate, HRV, physiological state) via proprietary AI models trained on millions of heartbeats, delivered through scalable cloud infrastructure and a REST API for partner integration.
• MindMics Inside Program B2B program allowing chipset, earbud OEM/ODM, and electronics manufacturers to embed MindMics infrasonic biosensing into their devices, including firmware libraries, turnkey integration support, and access to the MindMics API. Currently supports Qualcomm S5 Sound Platform and QCC5141, with Airoha chipset support.
• MindMics White-Label App
• MindMics REST API Cloud-based API that delivers real-time biometric data, including inter-beat intervals, heart rate (10-second windows), HRV (30-second windows), and physiological state classifications, to partner applications for integration into closed-loop wellness, gaming, telehealth, and digital health solutions.
• Infrasonic Lab Services

Quantifiable outcome

• 99% correlation to ECG for heart rate and HRV measurements
• +4 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability5 records

Feature8 records

Partnerships

Nine partnerships are on record, tiered core, key and supporting.

• QualcommcoreTechnology or Integration · 1 March 2023MindMics joined the Qualcomm Voice and Music Extension Program in March 2023, enabling its in-ear infrasonic hemodynography technology on the Qualcomm S5 Sound Platform (QCC5171) and QCC5141 platform. This marked the first health monitoring solution in the Extension program, accelerating commercialization of earbud-based health monitoring through Qualcomm's chipset ecosystem.
• MassAITC (Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease)coreStrategic or Co-development Partner · 1 January 2023MassAITC awarded $1.7 million to seven pilot projects including MindMics for AI and technology to support aging and Alzheimer's care. MindMics project focuses on vascular aging using infrasonic hemodynography embedded into everyday earbuds, conducted in collaboration with UMass Amherst.
• Master & DynamiccoreOEM/ Whitelabel/ Licensing PartnerPartnership with Master & Dynamic provides premium, white-label earbud solution with MindMics technology pre-integrated. B2B partners can source complete hardware plus integrated health monitoring technology through this partnership.
• a2 CollectivecoreStrategic or Co-development PartnerMindMics is a portfolio member of the AgeTech Collaborative (ATC) and completed an agreement with a2 Collective, a testbed dedicated to helping Americans live longer through AI and emerging technologies. The partnership focuses on vascular aging research using infrasonic hemodynography embedded in everyday earbuds, including grant-funded study in collaboration with MassAITC and UMass Amherst.
• AgeTech Collaborative (ATC)keyStrategic or Co-development PartnerMindMics is a startup portfolio member of the AgeTech Collaborative (ATC), gaining access to opportunities, resources, and partnerships within the aging-focused technology ecosystem.
• Prisma Health / University of South CarolinacoreStrategic or Co-development PartnerClinical validation partnership for atrial fibrillation detection study. Principal investigator Dr. Roosevelt Gilliam III led clinical trial demonstrating MindMics can detect heart rhythms as complex as atrial fibrillation with ECG-level accuracy.
• Scripps HealthcoreStrategic or Co-development PartnerClinical validation partnership for hemodynamics research. Principal investigator Dr. Sanjeev Bhavanani demonstrated high correlation between MindMics earbud bio-signals, echocardiography, and cardiac catheterizations for capturing cardiovascular performance measures.
• MassChallengesupportingOthersMindMics is part of the MassChallenge ecosystem, supporting startup growth and development.
• Harvard Innovation LabssupportingOthersMindMics is associated with Harvard Innovation Labs, connecting with Harvard's entrepreneurial ecosystem for technology development.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Whoop: Whoop is a subscription-based wearable for continuous HR, HRV, sleep, and recovery monitoring — the same biometric categories MindMics targets via its API and consumer subscription. Comparable as a recurring-revenue wellness biometrics company, though on the wrist rather than in-ear.
• Withings: Withings produces connected health devices (watches, blood pressure monitors, sleep analyzers) under a hybrid hardware-plus-subscription model. Comparable as a consumer health hardware brand pursuing clinical-grade metrics (ECG, blood pressure) — similar form-factor and pricing strategy to MindMics' Heart Health System.
• Masimo (including its consumer division): Masimo is a hospital-grade patient monitoring company that has expanded into consumer audio/biosensing (e.g., acquired Sound United's health-adjacent assets). It competes with MindMics in both clinical RPM and consumer-grade biosensing, with far greater scale and regulatory infrastructure.
• Oura Health: Oura sells a subscription-based smart ring focused on HRV, sleep, and recovery. Comparable to MindMics' consumer biometric subscription model and Heart Health System use cases around HRV-driven stress and recovery insights, though on a different body location.
• Apple (Apple Watch / AirPods health features): Apple offers ECG capability on Apple Watch and is extending health features into AirPods. It is the broadest incumbent competing for in-ear and on-wrist biometric monitoring across both consumer and clinical channels, with massive installed-base advantages over MindMics.

Direct peers

• iRhythm Technologies: iRhythm's Zio wearable cardiac monitor provides continuous ambulatory ECG monitoring for arrhythmia detection. It competes with MindMics in the clinical-grade cardiac monitoring and arrhythmia detection space, particularly for AF detection where MindMics has demonstrated 99% ECG correlation.
• Valencell: Valencell develops biometric sensor technology for hearables, wearables, and earbuds (PPG-based, with newer cuffless blood pressure work). It licenses to OEMs and consumer audio brands similar to MindMics' MindMics Inside program, making it a direct comparably-positioned biosensing IP licensor for earbud OEMs.
• AliveCor: AliveCor makes KardiaMobile, a consumer and clinical ECG device for cardiac rhythm monitoring (including AF detection). Like MindMics, it sells both direct-to-consumer cardiac monitoring and B2B/clinical-grade cardiac insights, and is also pursuing wearable form-factor expansion. Highly comparable as a consumer-first cardiac biosensing company pursuing clinical validation.

Emerging players

• Cambridge Sound Analytics (now part of Meta) / similar in-ear audio AI startups: Cambridge Sound Analytics was an early-stage company developing in-ear acoustic sensing and AI for health, mood, and biometric monitoring. Closely comparable to MindMics' overlap of audio AI applied to in-ear biosignals, and representative of the broader emerging-player pool (e.g., respectively renamed Cardinal Peak or acquired by larger players) in this niche.

Others

• Bose (hearables + health division): Bose is a premium consumer audio brand with deep roots in acoustics, noise cancellation, and hearables — and is home to a key MindMics advisor (Martin Ring, 25 years). Bose's potential entry into in-ear biosensing directly overlaps MindMics' OEM-partnership landscape and represents both a competitor and a candidate licensing customer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds4 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MindMics